Source of funding and outcome of clinical trials

Cited by (397)

Items 101–200 of 397

1. Prevalence and Outcomes of Pharmaceutical Industry—Sponsored Clinical Trials Involving Clozapine, Risperidone, or Olanzapine
   R. Procyshyn, A. Chau, P. Fortin, Willough Jenkins · 2004 · Canadian journal of psychiatry. Revue canadienne de psychiatrie
2. Association of Industry Sponsorship to Published Outcomes in Gastrointestinal Clinical Research
   Alphonso Brown, Daniel Kraft, Sarah M. Schmitz, Virginia Sharpless, Christopher Martin, Ritesh Shah, Nicholas J. Shaheen · 2006 · Clinical Gastroenterology and Hepatology
3. Explanation and Elaboration Document for the STROBE ‐Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology – Veterinary Extension
   Annette M. Cormier O'Connor, Jan Merrill Sargeant, Ian R. Dohoo, Hollis Nancy Erb, Myriam Cevallos, Matthias Egger, Annette Kjær Ersbøll, S. W. Martin, Liza Rosenbaum Nielsen, David L. Pearl et al. · 2016 · Zoonoses and Public Health
4. Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform
   M. Rodwin · 2012 · Journal of Law, Medicine & Ethics
5. Poverty, Environment, and Health
   Marie S. O’Neill, Anthony John McMichael, Joel David Schwartz, Daniel E. Wartenberg · 2007 · Epidemiology
6. The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem
   Amy C. Brodkey · 2005 · Academic Psychiatry
7. Conflict of Interest and Cost-effectiveness Analysis
   Sheldon Krimsky · 1999 · JAMA
8. Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology
   K.S. Knox, Jared R. Adams, Benjamin Djulbegović, T J Stinson, C. Tomori, Charles L. Bennet · 2000 · Annals of Oncology
9. Running an ethical trial 60 years after the Nuremberg Code.
   Jonathan Markman, M. Markman · 2007 · The Lancet Oncology
10. Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy
    Warren Pearce, Sujatha Raman, Andrew James Turner · 2015 · Trials
11. Getting it right: industry sponsorship and medical research.
    Patricia A. Baird · 2003 · Europe PMC (PubMed Central)
12. Discordance Between Conclusions Stated in the Abstract and Conclusions in the Article: Analysis of Published Randomized Controlled Trials of Systemic Therapy in Lung Cancer
    Altwairgi, Abdullah K., Booth, Christopher M., Hopman, Wilma M., Baetz, Tara D. · 2012 · Journal of Clinical Oncology
13. Positive-outcome bias: comparison of emergency medicine and general medicine literatures.
    R. Moscati, Dietrich Jehle, David G. Ellis, A. Fiorello, Michael K. Landi · 2008 · Academic Emergency Medicine
14. Sunshine Act: shedding light on inaccurate disclosures at a gynecologic annual meeting
    Jennifer C. Thompson, Katherine A. Volpe, Lindsay K. Bridgewater, Fares Qeadan, Gena C. Dunivan, Yuko M. Komesu, Sara B. Cichowski, Peter C. Jeppson, Rebecca Glenn Rogers · 2016 · American Journal of Obstetrics and Gynecology
15. A Review of the Types of Scientific Misconduct in Biomedical Research
    Malhar N. Kumar · 2008 · Journal of Academic Ethics
16. Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations
    M. Hartmann, H. Knoth, D. Schulz, S. Knoth · 2003 · British Journal of Cancer
17. Randomized clinical trials: what gets published, and when?
    Laurence Hirsch · 2004 · Europe PMC (PubMed Central)
18. Conflict of interest in industrysponsored economic evaluations: Real or imagined?
    Marco Barbieri, Michael Drummond · 2001 · Current Oncology Reports
19. Industry Reimbursement for Entering Patients into Clinical Trials: Legal and Ethical Issues
    David S. Shimm, Roy G. Spece · 1991 · Annals of Internal Medicine
20. Financial Conflict of Interest: an Unresolved Ethical Frontier
    Jerome P. Kassirer · 2001 · American Journal of Law & Medicine
21. Discrepancy between Results and Abstract Conclusions in Industry- vs Nonindustry-funded Studies Comparing Topical Prostaglandins
    Tariq A. Alasbali, Michael Robert Smith, Noa Geffen, Graham E. Trope, John G. Flanagan, Ya-Ping Jin, Yvonne M. Buys · 2008 · American Journal of Ophthalmology
22. Guidelines for Clinical Investigator Involvement in Industry‐sponsored Clinical Trials
    Edward A. Panacek, Roger J. Lewis · 1995 · Academic Emergency Medicine
23. The Impact of Corporate Payments on Robotic Surgery Research
    Cory N. Criss, Mark MacEachern, Niki Matusko, Justin Brigham Dimick, Melinda A Maggard-Gibbons, Samir K. Gadepalli · 2018 · Annals of Surgery
24. Thirty years of disclosure of conflict of interest in surgery journals
    Pascal Probst, Felix Jakob Hüttner, Ulla Klaiber, Markus K. Diener, Markus Wolfgang Büchler, Phillip Knebel · 2015 · Surgery
25. Assessing faculty financial relationships with industry: A case study.
    Elizabeth A. Boyd, Lisa Bero · 2000 · Journal of the American Medical Association (JAMA)
26. Accepting commercial sponsorship
    Lisa Anne Bero · 1999 · BMJ
27. Beyond publication bias
    Leon Bax, Karel G.M. Moons · 2010 · Journal of Clinical Epidemiology
28. La ciencia que no enseñamos
    Juan Miguel Campanario · 1999 · Enseñanza de las Ciencias Revista de investigación y experiencias didácticas
29. Financial Conflicts of Interest in Human Subjects Research: The Problem of Institutional Conflicts
    Mark Barnes, Patrik S. Florencio · 2002 · Journal of Law, Medicine & Ethics
30. Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.
    Susannah L. Rose, M. Krzyzanowska, S. Joffe · 2010 · Journal of Clinical Oncology
31. Ethical considerations in the relationship between physicians and the pharmaceutical industry
    Ashley D. Wazana, François J. Primeau · 2002 · Psychiatric Clinics of North America
32. In Search of the Magic Nutraceutical: Problems with Current Approaches
    Daren Keith Heyland · 2001 · Journal of Nutrition
33. Does palliative care have a role in treatment of anorexia nervosa?We should strive to keep patients alivePalliative care does not mean giving up
    Christopher J Williams, Lynne Russon, Lorenzo Pieri, Andrew Sims, D. L. Alison · 1998 · BMJ
34. Spheres of Morality: The Ethical Codes of the Medical Profession
    Samuel N. Doernberg, Robert D. Truog · 2023 · The American Journal of Bioethics
35. Journal Policies on Conflict of Interest: If this Is the Therapy, What’s the Disease?
    Sheldon Krimsky · 2001 · Psychotherapy and Psychosomatics
36. Discontinuation and Non-Publication of Heart Failure Randomized Controlled Trials: A Call to Publish All Trial Results
    Muhammad Shahzeb Khan, Izza Shahid, Nava Asad, Stephen John Greene, Safi Ullah Khan, Rami Doukky, Marco Metra, Stefan D. Anker, Gerasimos S Filippatos, Gregg C. Fonarow et al. · 2020 · ESC Heart Failure
37. α1-Blocker Therapy for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: What Are the Relevant Differences in Randomised Controlled Trials?
    Christian de Mey · 2000 · European Urology
38. Patent foramen ovale closure and migraine: science and sensibility
    Vinod Kumar Gupta · 2010 · Expert Review of Neurotherapeutics
39. Alternative treatments in reproductive medicine: much ado about nothing: `The fact that millions of people do not master arithmetic does not prove that two times two is anything else than four': W.F.Hermans
    Cees N. M. Renckens · 2002 · Human Reproduction
40. Industry-funded Positive Studies Not Associated with Better Design or Larger Size
    Mary R.A. Cunningham, Winston J. Warme, Douglas C. Schaad, Fredric M. Wolf, Seth S. Leopold · 2006 · Clinical Orthopaedics and Related Research
41. The commercialization of the biomedical sciences: (mis)understanding bias
    Inmaculada de Melo‐Martín · 2019 · History & Philosophy of the Life Sciences
42. Financial Conflicts of Interest and Study Results in Environmental and Occupational Health Research
    Lee S. Friedman, Michael Friedman · 2016 · Journal of Occupational and Environmental Medicine
43. Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
    Arman Shafiee, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari, Kyana Jafarabady, Sepehr Siahvoshi, Sayed‐Hamidreza Mozhgani · 2022 · Virology Journal
44. When Labels Mask Oppression: Implications for Teaching Psychiatric Taxonomy to Mental Health Counselors
    Lisa Cosgrove · 2005 · Journal of Mental Health Counseling
45. Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies
    Anke Huss, Matthias Egger, Kerstin Hug, Karin Huwiler, Martin Röösli · 2008 · Ciência & Saúde Coletiva
46. Research Accountability and Financial Conflicts of Interest in Industry Sponsored Clinical Research: A Review
    Patricia M. Tereskerz · 2003 · Accountability in Research
47. The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: secondary analysis of a systematic review
    Gerald Gartlehner, Laura C Morgan, Patricia Thieda, Anthony Fleg · 2009 · Journal of Clinical Epidemiology
48. Facing the Credibility Crisis of Science: On the Ambivalent Role of Pluralism in Establishing Relevance and Reliability
    MARTIN J. CARRIER · 2017 · Perspectives on Science
49. Evidence-Based Medicine for Neurosurgeons: Introduction and Methodology
    Mark E. Linskey · 2006 · KARGER eBooks
50. The pipeline and the porcupine: alternate metaphors of the physician–industry relationship
    Charles Mather · 2004 · Social Science & Medicine
51. Institute for Health Policy Studies
    UC San Francisco, Rachel Abraham Joseph · 2005
52. Assessment of Publication Bias in Dental Specialty Journals
    Argy Polychronopoulou, Nikolaos Pandis, Theodore Eliades · 2010 · Journal of Evidence Based Dental Practice
53. Survey of Conflict-of-Interest Disclosure Policies of Ophthalmology Journals
    Ayako Anraku, Ya-Ping Jin, Graham E. Trope, Yvonne M. Buys · 2009 · Ophthalmology
54. Recent Trends and Controversies in Industry‐sponsored Clinical Trials
    Caitlin R. Reed, Carlos A. Camargo · 1999 · Academic Emergency Medicine
55. Conflict of interest in psychiatry
    Syed Ahmer, Pradeep Arya, Duncan Anderson, Rafey A. Faruqui · 2005 · Psychiatric Bulletin
56. Decolonizing Knowledge Upstream: New Ways to Deconstruct and Fight Disinformation in an Era of COVID-19, Extreme Digital Transformation, and Climate Emergency
    Vural Özdemir, Simon Springer · 2022 · OMICS A Journal of Integrative Biology
57. Assessment of publication bias required improvement in oral health systematic reviews
    Despina Koletsi, Kalliopy Valla, Padhraig S. Fleming, Anna Chaimani, Nikolaos Pandis · 2016 · Journal of Clinical Epidemiology
58. The Relationship Between Industry and Surgery
    Kevin C. Chung, Sandra V. Kotsis, Richard A. Berger, Gordon Van Ummersen · 2011 · The Journal Of Hand Surgery
59. PREVALENCE OF INDUSTRY SUPPORT AND ITS RELATIONSHIP TO RESEARCH INTEGRITY
    Patricia M. Tereskerz, A. Hamric, Thomas M. Guterbock, J. Moreno · 2009 · Accountability in Research
60. Funding, objectivity and the socialization of medical research
    James Robert Brown · 2002 · Science and Engineering Ethics
61. Workshop Proceedings: Managing Conflict of Interest in Science. A Little Consensus and A Lot of Controversy
    Jacques P.J. Maurissen · 2005 · Toxicological Sciences
62. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
    Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman, Peter Christian Gøtzsche, Cynthia D. Mulrow, Stuart Pocock, Charles Poole, James J. Schlesselman, Matthias Egger · 2022 · Вопросы современной педиатрии
63. Evidence-Based Decision-Making 2: Systematic Reviews and Meta-Analysis
    Aminu Kasarawa Bello, Ben Vandermeer, Natasha Wiebe, Amit X. Garg, Marcello A. Tonelli · 2021 · Methods in molecular biology
64. The Evidence Thing
    Ramón Berguer · 2004 · Annals of Vascular Surgery
65. The Connection Between Academia and Industry
    Ajai R. Singh, Shakuntala A. Singh · 2005 · Mens Sana Monographs
66. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States
    Rishi Bansal, Rishad Khan, Michael A. Scaffidi, Nikko Gimpaya, Shai Genis, Abbas Ali Bukhari, Jeevan Dhillon, Kathy Dao, Chris Bonneau, Samir C. Grover · 2019 · Gastrointestinal Endoscopy
67. Evidence-Based Decision-Making 2: Systematic Reviews and Meta-analysis
    Aminu K. Bello, Natasha Wiebe, Amit X. Garg, Marcello A. Tonelli · 2015 · Methods in molecular biology
68. Conflicts of Interest and AJRCCM : Restating Policy and a New Form to Upload
    Martin J. Tobin · 2003 · American Journal of Respiratory and Critical Care Medicine
69. Conflict of Interest in the Physician Interface with the Biomedical Industry
    Hal J. Minnigan, Carey D. Chisholm · 2006 · Emergency Medicine Clinics of North America
70. Acupuncture for Major Depressive Disorder
    Albert Yeung, David Mischoulon · 2007 · The Journal of Clinical Psychiatry
71. Correlation Between Financial Relationships With Commercial Interests and Research Prominence at an Oncology Meeting
    Beverly Moy, Angela R. Bradbury, Paul R. Helft, Brian Lee Egleston, Moktar Sheikh-Salah, Jeffrey M. Peppercorn · 2013 · Journal of Clinical Oncology
72. Influence of study sponsorship on head and neck cancer randomized trial results
    Gordon H. Sun, J. Houlton, M. Maceachern, C. Bradford, Rodney A. Hayward · 2012 · Head and Neck
73. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. Translation to Russian
    Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman, Peter Christian Gøtzsche, Cynthia D. Mulrow, Stuart Pocock, Charles Poole, James J. Schlesselman, Matthias Egger · 2021 · Digital Diagnostics
74. Has health economics lost its way?
    David P. Kernick · 1998 · BMJ
75. Money, Method and Medical Research
    James Robert Brown · 2004 · Episteme
76. La declaración del conflicto de intereses en las publicaciones científicas. ¿Tiempo para las luces y los taquígrafos en la trastienda de la investigación financiada por la industria?
    S. Peiró, A. Garcia-altes, R. Meneu, J. Librero, E. Bernal · 2000 · Gaceta Sanitaria
77. Clinical trials, epidemiology, and public confidence
    DANIEL G. SEIGEL · 2003 · Statistics in Medicine
78. Bushwhacking the Ethical High Road: Conflict of Interest in the Practice of Law and Real Life
    Susan P. Shapiro · 2003 · Law & Social Inquiry
79. Conflict, what conflict?
    Michael S. Wilkes · 2000 · Western Journal of Medicine
80. The Use of Meta‐analysis in Pharmacoepidemiology
    Jesse A. Berlin · 2000 · Pharmacoepidemiology
81. Sponsorship, authorship, and accountability
    Paul S. Thomas, Ken‐Soon Tan, Deborah Helwen Yates · 2002 · The Lancet
82. A comparison of the scientific quality of publicly and privately funded randomized controlled drug trials
    Richard Jones, Stuart Younie, Andrew Macallister, Jim Thornton · 2010 · Journal of Evaluation in Clinical Practice
83. Ethical control of innovation in a globalized and liberal world: Is good science still science?
    Éric Muraille · 2019 · Endeavour
84. Pitfalls in the publication of scientific literature: a road map to manage conflict of interest and other ethical challenges
    Alpesh A. Patel, Peter G. Whang, Andrew P. White, Michael George Fehlings, Alexander Richard Vaccaro · 2010 · Journal of neurosurgery
85. Characteristics of NIH- and industry-sponsored head and neck cancer clinical trials
    Anand K. Devaiah, Charles Murchison · 2016 · The Laryngoscope
86. Does a drug do better when it is new?
    Roldano Fossati, Carlo Confalonieri, Giovanni Apolone, Silvio Cavuto, Silvio K. Garattini · 2002 · Annals of Oncology
87. Issues in publication and interpretation of research findings
    Moysés Szklo · 1991 · Journal of Clinical Epidemiology
88. Recommendations for the Relationship Between Sponsors and Investigators in the Design and Conduct of Clinical Stroke Trials
    Geoffrey Alan Donnan, Stephen M. Davis, Markku Kaste · 2003 · Stroke
89. Assessing the robustness of negative vascular surgery randomized controlled trials using their reverse fragility index
    Allen Li, Arshia Pedram Javidan, Eva Liu, Aryan Ahmadvand, Derrick Y. Tam, Faysal N. Naji, Thomas L. Forbes · 2022 · Journal of Vascular Surgery
90. Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology
    Clayton Velicer, Gideon St. Helen, Stanton A. Glantz · 2017 · Journal of Public Health Policy
91. Primer on Systematic Review and Meta-Analysis
    Marcello A. Tonelli, Dan G. Hackam, Amit X. Garg · 2008 · Methods in molecular biology
92. Independent Investigators and For-Profit Companies
    Mary‐Margaret Chren · 1994 · Archives of Dermatology
93. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration — a Korean translation
    Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman, Peter Christian Gøtzsche, Cynthia D. Mulrow, Stuart Pocock, Charles Poole, James J. Schlesselman, Matthias Egger · 2024 · Ewha Medical Journal
94. Clinical Investigators and the Pharmaceutical Industry
    Thomas S. Bodenheimer · 2000 · New England Journal of Medicine
95. Reviews of materials in the WHO/HAI database on drug promotion
    Pauline Norris, Andrew Herxheimer, Joel Lexchin, Peter R. Mansfield · 2004
96. Conflicts of interest in drug development: The practices of Merck & Co., Inc.
    Laurence J Hirsch · 2002 · Science and Engineering Ethics
97. Who's Buying Lunch: Are Gifts to Surgeons from Industry Bad for Patients?
    David C. Grant, Kenneth Victor Iserson · 2005 · Thoracic surgery clinics/Thorac. surg. clin.
98. Why Should Philosophers of Science Pay Attention to the Commercialization of Academic Science?
    Gürol Irzık · 2009 · Springer eBooks
99. Conducting industry-partnered trials in orthopaedic surgery
    Mohit Bhandari, Anders Jönsson, V. Bühren · 2006 · Injury
100. Meta‐analysis in transfusion medicine
     EC Vamvakas · 1997 · Transfusion